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Despite significant advances in research, breast cancer is
still the most common form of cancer, with 50,000 cases
diagnosed and 12,000 dying of the disease each year in
the UK. In October 2013, Breast Cancer Campaign
published a Gap Analysis of breast cancer research that
provides us with what we need to know about and what
we now need to do to overcome – prevent, cure and
outlive – breast cancer. In addition to highlighting the
gaps in our understanding of breast cancer, the paper
identifies five strategic solutions, which require a
collaborative approach amongst researchers in academia
and industry, funders, donors, policy-makers and
parliamentarians, healthcare professionals and patients to
achieve significant progress. Breast Cancer Campaign is
calling for funding organizations to reverse the decline in
resources targeted towards breast cancer research, an
improved and collaborative infrastructure to support
breast cancer research, multidisciplinary collaboration and
improved clinical trial design. We hope that breast cancer
can be overcome by 2050, but this can only be achieved
through collaboration with others. The actions that will
make a difference have been identified and we must
act now.sionals and patients to achieve significant progress.Help us find the cures
Despite significant advances in research, breast cancer is
still the most common form of cancer, with 50,000 cases
diagnosed and 12,000 dying of the disease each year in the
UK. The goal of Breast Cancer Campaign is to change this.Identifying the gaps
In 2008, Breast Cancer Campaign published its first Gap
Analysis paper, which identified the gaps that existed in
breast cancer research that, if addressed, would acceler-
ate research progress [1]. A key issue highlighted by theCorrespondence: ChiefExec@breastcancercampaign.org
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© BioMed Central Ltd.201356 authors was the lack of access to high-quality clinical
material, leading Breast Cancer Campaign to establish
the UK’s first ever national breast cancer tissue bank, a
unique collaboration with four leading institutions [2].
Five years on, Breast Cancer Campaign has published
their second Gap Analysis, which provides a detailed as-
sessment of what we need to know about and what we
now need to do to overcome – prevent, cure and outlive –
breast cancer [3]. Involving over 100 internationally recog-
nized scientists, clinicians, healthcare experts and patients,
we believe it to be the most comprehensive analysis of
breast cancer research ever to have taken place.
The top 10 gaps have been identified and prioritised in
key areas, such as genetics, prevention, diagnosis, treat-
ment and support. We are heading towards a future where
breast cancer can be overcome and outlived. But to reach
vital milestones, as a community we must address these
critical gaps now.Time to act
In addition to highlighting the gaps in our understand-
ing of breast cancer, the paper identifies five strategic so-
lutions, which require a collaborative approach amongst
researchers in academia and industry, funders, donors,
policy-makers and parliamentarians, healthcare profes-
To accompany the Gap Analysis paper, Breast Cancer
Campaign has published ‘Help us find the cures: An ac-
tion plan to tackle critical gaps in breast cancer research’,
which sets out the charity’s ambitions for the future and
pinpoints 66 specific actions that will be crucial in filling
the gaps [4]. The paper calls for funding organizations to
reverse the decline in resources targeted towards breast
cancer research, an improved and collaborative infrastruc-
ture to support breast cancer research, multidisciplinary
collaboration and improved clinical trial design.
A key priority for accelerating progress is the routine
collection and use of sequential human breast cancer tis-
sue and blood samples, both during cancer development
and treatment as well as from local and distant recur-
rences. In response to recent evidence showing that a
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change the way one in six women are treated, we are
calling on the National Institute for Health and Care Ex-
cellence to review their advanced breast cancer guideline.
Over the next 5 years we will also invest in a significant
expansion of the Breast Cancer Campaign Tissue Bank,
addressing existing gaps in tissue, data, biomarkers and
models to become one of the world’s leading banks for
breast cancer-related research materials. We will expand
our collection of metastatic cancer samples and begin to
collect sequential tissue samples, enabling scientists to
study treatment response, resistance, indicators of relapse
and progression from primary to metastatic cancers. To
accelerate progress in risk, prevention and imaging re-
search, we will also introduce the routine collection of
breast density data and mammographic imaging alongside
samples, as well as developing a mechanism to collect nor-
mal breast tissue. However, implementing these changes
will require the cooperative efforts of our community –
collaboration will be critical to create a central, well-
organized and utilized biobanking resource for breast
cancer research.
The charity aims to raise more than £100 million over
the next decade to specifically target the critical gaps in
breast cancer research, increasing previous investment
in every area of our work. We are aiming to increase our
investment in research in upcoming grant rounds and
are currently seeking high-quality research proposals to
tackle the gaps. Expanding beyond our grant funding
schemes, we have also created the new Collaborators for
a Cure Fund dedicated to addressing the critical research
gaps, and we are keen to hear from anyone wanting to
discuss new collaborations and initiatives.
Breast Cancer Campaign hopes that breast cancer can
be overcome – prevented, cured and outlived – by 2050,
but this can only be achieved through collaboration with
others. The government, academics, clinicians, health-
care professionals, charities, funding bodies and all those
that care about breast cancer need to work together to
plug the gaps.
The actions needed to make the difference have been
identified and we must act now. Please visit the website
for details on how to apply for research funding or tissue
samples, and for information on collaborating with
Breast Cancer Campaign to address the gaps [4].
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